EU Legislators Firm Up Commission’s Plans To Overhaul Pharma Rules
Parliamentary Report Gets Mixed Reception From Industry
Efforts to overhaul the EU pharmaceutical legislation have been given added impetus after the European Parliament called for action to boost innovation and medicines access, shore up manufacturing and supply chains, and examine the link between R&D spending and drug prices.
